Anne R J Dekker1, Theo J M Verheij2, Alike W van der Velden2. 1. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (STR 6.103), Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. a.r.j.dekker-8@umcutrecht.nl. 2. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (STR 6.103), Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Abstract
BACKGROUND: Numerous studies suggest overprescribing of antibiotics for respiratory tract indications (RTIs), without really authenticating inappropriate prescription; the strict criteria of guideline recommendations were not taken into account as information on specific diagnoses, patient characteristics and disease severity was not available. OBJECTIVE: The aim of this study is to quantify and qualify inappropriate antibiotic prescribing for RTIs. METHODS: This is an observational study of the (antibiotic) management of patients with RTIs, using a detailed registration of RTI consultations by general practitioners (GPs). Consultations of which all necessary information was available were benchmarked to the prescribing guidelines for acute otitis media (AOM), acute sore throat, rhinosinusitis or acute cough. Levels of overprescribing for these indications and factors associated with overprescribing were determined. RESULTS: The overall antibiotic prescribing rate was 38%. Of these prescriptions, 46% were not indicated by the guidelines. Relative overprescribing was highest for throat (including tonsillitis) and lowest for ear consultations (including AOM). Absolute overprescribing was highest for lower RTIs (including bronchitis). Overprescribing was highest for patients between 18 and 65 years of age, when GPs felt patients' pressure for an antibiotic treatment, for patients presenting with fever and with complaints longer than 1 week. Underprescribing was observed in <4% of the consultations without a prescription. CONCLUSION: Awareness of indications and patient groups provoking antibiotic overprescribing can help in the development of targeted strategies to improve GPs' prescribing routines for RTIs.
BACKGROUND: Numerous studies suggest overprescribing of antibiotics for respiratory tract indications (RTIs), without really authenticating inappropriate prescription; the strict criteria of guideline recommendations were not taken into account as information on specific diagnoses, patient characteristics and disease severity was not available. OBJECTIVE: The aim of this study is to quantify and qualify inappropriate antibiotic prescribing for RTIs. METHODS: This is an observational study of the (antibiotic) management of patients with RTIs, using a detailed registration of RTI consultations by general practitioners (GPs). Consultations of which all necessary information was available were benchmarked to the prescribing guidelines for acute otitis media (AOM), acute sore throat, rhinosinusitis or acute cough. Levels of overprescribing for these indications and factors associated with overprescribing were determined. RESULTS: The overall antibiotic prescribing rate was 38%. Of these prescriptions, 46% were not indicated by the guidelines. Relative overprescribing was highest for throat (including tonsillitis) and lowest for ear consultations (including AOM). Absolute overprescribing was highest for lower RTIs (including bronchitis). Overprescribing was highest for patients between 18 and 65 years of age, when GPs felt patients' pressure for an antibiotic treatment, for patients presenting with fever and with complaints longer than 1 week. Underprescribing was observed in <4% of the consultations without a prescription. CONCLUSION: Awareness of indications and patient groups provoking antibiotic overprescribing can help in the development of targeted strategies to improve GPs' prescribing routines for RTIs.
Authors: Ole Köhler-Forsberg; Liselotte Petersen; Christiane Gasse; Preben B Mortensen; Soren Dalsgaard; Robert H Yolken; Ole Mors; Michael E Benros Journal: JAMA Psychiatry Date: 2019-03-01 Impact factor: 21.596
Authors: Koen B Pouwels; F Christiaan K Dolk; David R M Smith; Julie V Robotham; Timo Smieszek Journal: J Antimicrob Chemother Date: 2018-02-01 Impact factor: 5.790
Authors: Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews Journal: Clin Microbiol Rev Date: 2018-12-12 Impact factor: 26.132
Authors: Lauren Breithaupt; Ole Köhler-Forsberg; Janne Tidselbak Larsen; Michael E Benros; Laura Marie Thornton; Cynthia M Bulik; Liselotte Petersen Journal: JAMA Psychiatry Date: 2019-08-01 Impact factor: 21.596
Authors: Adam J Schoenfeld; Jason M Davies; Ben J Marafino; Mitzi Dean; Colette DeJong; Naomi S Bardach; Dhruv S Kazi; W John Boscardin; Grace A Lin; Reena Duseja; Y John Mei; Ateev Mehrotra; R Adams Dudley Journal: JAMA Intern Med Date: 2016-05-01 Impact factor: 21.873
Authors: Roderick P Venekamp; Jeroen Hoogland; Maarten van Smeden; Maroeska M Rovers; An I De Sutter; Daniel Merenstein; Gerrit A van Essen; Laurent Kaiser; Helena Liira; Paul Little; Heiner Cc Bucher; Johannes B Reitsma Journal: BMJ Open Date: 2021-07-01 Impact factor: 2.692